1. Home
  2. FBK vs QURE Comparison

FBK vs QURE Comparison

Compare FBK & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FB Financial Corporation

FBK

FB Financial Corporation

N/A

Current Price

$51.70

Market Cap

2.6B

Sector

Finance

ML Signal

N/A

Logo uniQure N.V.

QURE

uniQure N.V.

N/A

Current Price

$19.33

Market Cap

3.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FBK
QURE
Founded
1906
1998
Country
United States
Netherlands
Employees
N/A
248
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
3.1B
IPO Year
2016
2013

Fundamental Metrics

Financial Performance
Metric
FBK
QURE
Price
$51.70
$19.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
13
Target Price
★ $63.38
$58.14
AVG Volume (30 Days)
285.7K
★ 1.7M
Earning Date
10-13-2026
11-04-2026
Dividend Yield
★ 1.62%
N/A
EPS Growth
N/A
★ 29.67
EPS
★ 3.43
N/A
Revenue
N/A
★ $13,107,000.00
Revenue This Year
$12.93
$39.49
Revenue Next Year
$6.20
$402.79
P/E Ratio
$15.14
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$49.67
$8.73
52 Week High
$62.66
$51.72

Technical Indicators

Market Signals
Indicator
FBK
QURE
Relative Strength Index (RSI) 36.53 31.36
Support Level $50.52 $13.96
Resistance Level $53.56 $26.07
Average True Range (ATR) 1.27 1.70
MACD -0.33 -0.05
Stochastic Oscillator 0.61 0.49

Price Performance

Historical Comparison
FBK
QURE

About FBK FB Financial Corporation

FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates majority of revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

Share on Social Networks: